Full Event Guide

Brochure Cover

Having issues downloading?
Click here

Why this is an unmissable event:

  • Get involved in the preclinical discovery, validation and clinical development programs in IBD associated fibrosis with leaders from Cleveland Clinic, Genentech, and Boehringer Ingelheim
  • Explore the latest research into novel cell types with Takeda, Galecto, and Harvard Medical School to highlight innovative mechanistic pathways in order to promote tissue regeneration and better understand cross-disease mechanistic overlaps
  • Leverage updates in identifying innovative technologies, translational models and biomarkers tools for fibrosis with key leaders from GSK, AstraZeneca and Bristol Myers Squibb
  • Evaluate cutting-edge updates in recent clinical trials with ImmunoMet Therapeutics and Galmed Pharmaceuticals to learn from clinical setbacks and drive innovation in shaping future pipeline decisions